{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_Display\ Name in Display Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
BLA125408
(2016)
Source URL:
First approved in 2016
Source:
BLA125408
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125408
(2016)
Source URL:
First approved in 2016
Source:
BLA125408
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
PreGen DHA by Emerald Therapeutics, LLC
(2020)
Source URL:
First approved in 2013
Source:
FOSTEUM PLUS by Primus Pharmaceuticals, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125163
(2013)
Source URL:
First approved in 2013
Source:
BLA125163
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(2013)
Source URL:
First approved in 2013
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125462
(2013)
Source URL:
First approved in 2013
Source:
BLA125462
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125408
(2012)
Source URL:
First approved in 2012
Source:
BLA125408
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125296
(2011)
Source URL:
First approved in 2011
Source:
BLA125296
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Complete Natal DHA by Trigen Laboratories, LLC
(2010)
Source URL:
First approved in 2010
Source:
Complete Natal DHA by Trigen Laboratories, LLC
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(2009)
Source URL:
First approved in 2009
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE